Latest news
Health Canada review path for PrimeC: NeuroSense (NASDAQ: NRSN) - Stock TitanStock Titan · Thu, 06 Aug 2026 15:56:23 GMTNeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada - PR NewswirePR Newswire · Thu, 06 Aug 2026 15:29:00 GMTHealth Canada backlog of generic drug applications doubled over past year - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 19:05:55 GMTBiocon gets Health Canada nod for Yesintek autoinjector pen - ET PharmaET Pharma · Thu, 30 Jul 2026 07:12:55 GMT